Stefania Saragoni

RWE in oncology: use of databases to identify molecular subtypes of metastatic breast cancer in Italy

Maria Cappuccilli, Melania Leogrande, Stefania Saragoni, Andrea Luciani et autres

it (code pays fourni par la source)

Evaluation of biochemical and economic outcomes in patients treated with PCSK9 inhibitors in a real clinical practice setting

Melania Dovizio, Marta Nugnes, Biagio Iacolare, Stefania Saragoni et autres

gb, it (code pays fourni par la source)

Real World Evidence on Hormone Receptor Positive and Human Epidermal Growth Factor Receptor 2 Negative Metastatic Breast Cancer in Italy: Insights From 2017 to 2021 Data

Valentina Perrone, Melania Leogrande, Maria Cappuccilli, Stefania Saragoni et autres

The Integrated Multidisciplinary Pathway for Large-Scale Management of Dyslipidemia in High-Risk Patients (ENNA) Project: Rationale and Project Design

Federica Agnello, Colomba Russo, Giulia Laterra, Salvatore Ingala et autres

it, gb (code pays fourni par la source)

SA58 Meningococcal Serogroup B Vaccination Coverage of Infants, Children, & Adolescents in Different Regions in Italy: A Retrospective Administrative Database Study

G. Nikitas, S. Comparoni, Martina Nugnes, Stefania Saragoni et autres

be, it (code pays fourni par la source)

Real-World Data Analysis of Patients Affected by Immune-Mediated Thrombotic Thrombocytopenic Purpura in Italy

Emanuele Angelucci, Andrea Artoni, Luana Fianchi, Melania Dovizio et autres

it (code pays fourni par la source)

Real-World Data Analysis of Patients Affected by Acquired Thrombotic Thrombocytopenic Purpura in Italy

Emanuele Angelucci, Andrea Artoni, Luana Fianchi, Melania Dovizio et autres

it, gb (code pays fourni par la source)

PT36 Real-World Analysis on Therapeutic Pattern and Economic Burden of Androgen-Receptor Signaling Inhibitors (ARSI) and Taxane-Based Chemotherapy Treated Metastatic Castration-Resistant Prostate Cancer Patients in Italy

Melania Dovizio, Stefano Mazzoni, Carmela Nappi, Stefania Saragoni et autres

Estimation of patients affected by inflammatory bowel disease potentially eligible for biological treatment in a real-world setting

Luca Degli Esposti, Valentina Perrone, Diego Sangiorgi, Stefania Saragoni et autres

gb, it (code pays fourni par la source)

Fr555 HOW MANY PATIENTS AFFECTED BY CROHN'S DISEASE OR ULCERATIVE COLITIS NOT TREATED WITH BIOLOGIC AGENTS COULD BE ELIGIBLE FOR THESE THERAPIES IN ITALY?

Luca Degli Esposti, Valentina Perrone, Diego Sangiorgi, Stefania Saragoni et autres

Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy

Salvatore Petta, Jie Ting, Stefania Saragoni, Luca Degli Esposti et autres

ar, it, us (code pays fourni par la source)

Economic Burden of Osteoporotic Patients with Fracture: Effect of Treatment With or Without Calcium/Vitamin D Supplements

Luca Degli Esposti, Stefania Saragoni, Valentina Perrone, Stefania Sella et autres

it (code pays fourni par la source)